News
Novartis Launches India’s First Approved Radioligand Therapy for Advanced Prostate Cancer
The targeted radioligand therapy Pluvicto will initially be available through selected hospitals and nuclear medicine centres across India under Novartis’ partnership-led access model.
imphoenix82
- June 15, 2026
- 0 Comments
- 3 Views
-